Oral Engasertib Safe for Hereditary Hemorrhagic Telangiectasia

THURSDAY, Dec. 4, 2025-- For adult patients with hereditary hemorrhagic telangiectasia (HHT), a new, allosteric, selective activin receptor-like kinase 1 inhibitor, oral engasertib, is safe and is associated with decreases in epistaxis frequency...